Hugh Macnaught, Interim Chief Executive Officer at VentriPoint Diagnostics, holds 40.00K shares in VentriPoint Diagnostics (Ticker: TSE:VPT). Most recently, Hugh Macnaught Bought C$20,000 shares of VentriPoint Diagnostics on Apr 18, 2024 for an estimated value of 4.40K.